SCHEMBL108799

SCHEMBL108799

CCC(O)CCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.49
MMP2 P08253 1/20 0.49
MMP9 P14780 1/20 0.49
MMP12 P39900 1/20 0.49
MMP13 P45452 1/20 0.49
MMP14 P50281 1/20 0.49
TRPA1 O75762 1/20 0.47
SLC6A2 P23975 2/20 0.46
SLC6A4 P31645 2/20 0.46
SLC6A3 Q01959 2/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
KCNH2 Q12809 1/20 0.46
TSHR P16473 1/20 0.46
LMNA P02545 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
ANPEP P15144 2/20 0.44
ERAP1 Q9NZ08 2/20 0.44
ERAP2 Q6P179 1/20 0.44
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2524872 1.00 DPP4 (0.49) DPP4MMP2MMP9MMP12MMP13
SCHEMBL27897101 0.90 MMP12 (0.49) DPP4MMP2MMP9MMP12MMP13
SCHEMBL5950465 0.89 MMP12 (0.44) MMP2MMP9MMP12MMP13MMP14
SCHEMBL14088112 0.88 MMP12 (0.65) MMP2MMP9MMP12MMP13MMP14
SCHEMBL2820906 0.88 TRPA1 (0.50) TRPA1SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL4799370 0.86 MMP2 (0.55) DPP4MMP2MMP9MMP12MMP13
SCHEMBL1678559 0.86 TRPA1 (0.57) TRPA1
SCHEMBL14402642 0.85 TSHR (0.49) DPP4MMP2MMP9MMP12MMP13
SCHEMBL14968476 0.85 TSHR (0.49) DPP4MMP2MMP9MMP12MMP13
SCHEMBL2820904 0.85 TSHR (0.49) DPP4MMP2MMP9MMP12MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649183-A1 SILICONE COMPOUNDS The Procter and Gamble Company (US) 2020-05-13 EP claimed
WO-2019010263-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2019-01-10 WO claimed
EP-2463374-A2 Isolated alcohol dehydrogenase enzymes and uses thereof Bio Architecture Lab, Inc. (US) 2012-06-13 EP claimed
EP-2195440-A2 BIOFUEL PRODUCTION Bio Architecture Lab, Inc. (US) 2010-06-16 EP claimed
US-20090155873-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-18 US claimed
US-20090139134-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-04 US claimed
WO-2009046370-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
WO-2009046375-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
US-6939835-B2 Cyclic compounds and their use as precursors of fragrant alcohols FIRMENICH SA (CH) 2005-09-06 US claimed
EP-0919607-A2 Lubricant for mechanical working of materials and additive for the lubricant Rhenus Lub GmbH & Co. KG (DE) 1999-06-02 EP claimed
EP-0032576-B1 PROCESS FOR THE PREPARATION OF P-SUBSTITUTED PHENYL PROPANOLS AND THEIR ESTERS AND OF P-SUBSTITUTED 3-PHENYL-2-METHYL PROPANALS BASF Aktiengesellschaft (DE) 1983-08-10 EP claimed
JP-61293367-A None JP disclosed
JP-61293366-A None JP disclosed
EP-3191437-B1 PROCESS FOR HYDROXYLATING PHENOLIC SUBSTRATE SPECIALTY OPERATIONS FRANCE (FR) 2025-10-01 EP disclosed
EP-3230463-B2 RAPID PRETREATMENT APALTA PATENTS OUE (EE) 2025-07-16 EP disclosed
WO-1999014185-A1 COMPOUNDS CONTAINING SIX-MEMBERED RINGS, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS GILEAD SCIENCES, INC. (US) 1999-03-25 WO disclosed
JP-S61293367-A PRODUCTION OF MUSHROOM-LIKE FLAVOR T HASEGAWA CO LTD 1986-12-24 JP disclosed
JP-S61293366-A MUSHROOM FLAVOR COMPOSITION T HASEGAWA CO LTD 1986-12-24 JP disclosed
US-4072722-A OXIDIZING A MONOHYDRIC PHENOL WITH A KETONE PEROXIDE UBE INDUSTRIES, LTD. (JA) 1978-02-07 US disclosed
US-4013727-A OXIDATION OF PHENYL ETHERS WITH HYDROGEN PEROXIDE UBE INDUSTRIES, LTD. (JA) 1977-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090139134-A1 BIOFUEL PRODUCTION MGAM, DCXR, MANBA DPP4 961/4885MMP2 360/4885MMP9 728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.